Indivior Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · North Chesterfield, VA
INDV chart
What traders are saying about $INDV
Latest postsIndivior Pharmaceuticals, Inc. news
- Indivior Pharmaceuticals, Inc. Estimates – FWB:E7P
TradingView ·
- INDV Stock Price and Chart — NASDAQ:INDV
TradingView ·
- Indivior Pharmaceuticals (INDV) Agrees Supernus Deal, Is The Stock Still Cheap?
Simply Wall Street ·
- MSG Rangers and Huron Consulting Group Set to Join S&P SmallCap 600
Yahoo Finance ·
- Indivior Pharmaceuticals, Inc. (INDV) Stock Forecasts
Yahoo Finance ·
- Indivior to Report Third Quarter 2026 Financial Results
Yahoo Finance ·
- Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend
Yahoo Finance ·
- 5 Small Drug Stocks Poised to Benefit From a Biotech Recovery
Yahoo Finance ·
- Indivior Pharmaceuticals Inc. (INDV) Down 5.3% Since Last Earnings Report: Can It Rebound?
Yahoo Finance ·
- Indivior Pharmaceuticals Inc. (INDV) Loses 12.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Yahoo Finance ·
- 3 Reasons Why Growth Investors Shouldn't Overlook Indivior Pharmaceuticals Inc. (INDV)
Yahoo Finance ·
- Indivior Pharmaceuticals (INDV) Could Be 30% Undervalued On Its Cost Reset Plan
Yahoo Finance ·
Indivior Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $1.24B | $1.19B | $1.09B | $901.0M |
| Net income | $210.0M | $7.0M | -$126.0M | -$42.0M |
| Diluted EPS | $1.64 | $0.05 | $-0.92 | $-0.30 |
| Total assets (year end) | $1.20B | $1.32B | $1.76B | – |
| Cash and equivalents (year end) | $195.0M | $319.0M | $316.0M | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Indivior Pharmaceuticals, Inc.
- Ticker
- INDV (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- North Chesterfield, VA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1625297
- Former names
- INDIVIOR PLC
Frequently asked questions
What exchange is Indivior Pharmaceuticals, Inc. listed on?
Indivior Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol INDV.
What industry is Indivior Pharmaceuticals, Inc. in?
Indivior Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Indivior Pharmaceuticals, Inc. headquartered?
Indivior Pharmaceuticals, Inc.'s business address on file with the SEC is in North Chesterfield, VA.
When does Indivior Pharmaceuticals, Inc.'s fiscal year end?
Indivior Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Indivior Pharmaceuticals, Inc. report?
Indivior Pharmaceuticals, Inc. reported $1.24B in revenue for calendar year 2025, according to its SEC filings.